Stakeholders blast FDA panel’s rejection of MDMA therapy

Click in for more news from The Hill {beacon} Health Care Health Care The Big Story Stakeholders blast FDA panel’s rejection of MDMA therapy An advisory committee for the Food and Drug Administration (FDA) voted against recommending MDMA-assisted therapy for PTSD, drawing backlash from lawmakers and advocates. © AP The members of the FDA’s...